chr10-100529423-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005004.4(NDUFB8):āc.169A>Cā(p.Met57Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,612,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_005004.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NDUFB8 | NM_005004.4 | c.169A>C | p.Met57Leu | missense_variant | 2/5 | ENST00000299166.9 | |
NDUFB8 | NM_001284367.2 | c.169A>C | p.Met57Leu | missense_variant | 2/5 | ||
NDUFB8 | NM_001284368.1 | c.76A>C | p.Met26Leu | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NDUFB8 | ENST00000299166.9 | c.169A>C | p.Met57Leu | missense_variant | 2/5 | 1 | NM_005004.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152026Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000759 AC: 19AN: 250458Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135414
GnomAD4 exome AF: 0.0000698 AC: 102AN: 1460972Hom.: 0 Cov.: 32 AF XY: 0.0000729 AC XY: 53AN XY: 726782
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152026Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74246
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.169A>C (p.M57L) alteration is located in exon 2 (coding exon 2) of the NDUFB8 gene. This alteration results from a A to C substitution at nucleotide position 169, causing the methionine (M) at amino acid position 57 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with NDUFB8-related conditions. This variant is present in population databases (rs371166959, gnomAD 0.02%). This sequence change replaces methionine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 57 of the NDUFB8 protein (p.Met57Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at